AI has the potential to substantially transform hypertension management by enabling more precise, proactive, and personalized care but major barriers to implementation include data heterogeneity, algorithmic bias, limited interpretability, insufficient external validation, infrastructure and cost requirements, regulatory uncertainty, and concerns regarding patient trust and data privacy.
The principal challenge in modern HFrEF management is no longer the absence of effective therapies, but failure to deliver proven therapies rapidly, comprehensively, and sustainably.
Ehsan Shahverdi, Amin Shahverdi, Sendooran Shahi et al.· Journal of the Saudi Heart A...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.